Report 47: Blood System-Related Adverse Events Following Pfizer COVID-19 mRNA Vaccination
The War Room/DailyClout Pfizer Documents Analysis Project Post-Marketing Team created the following two-page Hematological System Organ Class (SOC) Review from data in Pfizer document 5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-FEB-2021 (a.k.a., “5.3.6“). The hematological system is the human body’s blood system and includes red cells, white cells, platelets, and clotting proteins. Viewing the blood components as a system, its Adverse Events (AEs) reports made up 2.2% (932 individuals) of the 42,086 total trial participants with AEs identified.
Fifty percent of the blood-related adverse events reported were noted within 48 hours of Pfizer COVID-19 mRNA vaccination, but there were also cases reported up to 33 days post-injection. In the hematological group of adverse events, there were 34 deaths and 17 cases of permanent damage.
It is important to note that the AEs in the 5.3.6 document were reported to Pfizer for only a 90-day period starting on December 1, 2020, the date of the United Kingdom’s public rollout of Pfizer’s COVID-19 experimental mRNA “vaccine” product.
DC V7 combined p1-2 Post Marketing Hematological MicroReport